Your browser doesn't support javascript.
loading
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
Johnston, Stephen; Puhalla, Shannon; Wheatley, Duncan; Ring, Alistair; Barry, Peter; Holcombe, Chris; Boileau, Jean Francois; Provencher, Louise; Robidoux, André; Rimawi, Mothaffar; McIntosh, Stuart A; Shalaby, Ibrahim; Stein, Robert C; Thirlwell, Michael; Dolling, David; Morden, James; Snowdon, Claire; Perry, Sophie; Cornman, Chester; Batten, Leona M; Jeffs, Lisa K; Dodson, Andrew; Martins, Vera; Modi, Arjun; Osborne, C Kent; Pogue-Geile, Katherine L; Cheang, Maggie Chon U; Wolmark, Norman; Julian, Thomas B; Fisher, Kate; MacKenzie, Mairead; Wilcox, Maggie; Huang Bartlett, Cynthia; Koehler, Maria; Dowsett, Mitch; Bliss, Judith M; Jacobs, Samuel A.
Afiliación
  • Johnston S; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.
  • Puhalla S; 2 Univeristy of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA.
  • Wheatley D; 3 Royal Cornwall Hospitals National Health Service Foundation Trust, Treliske, United Kingdom.
  • Ring A; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.
  • Barry P; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.
  • Holcombe C; 4 Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool, United Kingdom.
  • Boileau JF; 5 Montreal Jewish General Hospital Segal Cancer Centre, Montreal, Quebec, Canada.
  • Provencher L; 6 Centre Hospitalier Université de Quebec-Universite Laval, Quebec City, Quebec, Canada.
  • Robidoux A; 7 Centre Hospitalier Université de Montréal, Montreal, Quebec, Canada.
  • Rimawi M; 8 Baylor College of Medicine, Houston, TX.
  • McIntosh SA; 9 Queen's University Belfast, Belfast, United Kingdom.
  • Shalaby I; 10 Joe Arrington Cancer Research and Treatment Center, Lubbock, TX.
  • Stein RC; 11 National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom.
  • Thirlwell M; 12 University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.
  • Dolling D; 13 McGill University Health Centre, Montreal, Quebec, Canada.
  • Morden J; 14 The Institute of Cancer Research, London, United Kingdom.
  • Snowdon C; 14 The Institute of Cancer Research, London, United Kingdom.
  • Perry S; 14 The Institute of Cancer Research, London, United Kingdom.
  • Cornman C; 14 The Institute of Cancer Research, London, United Kingdom.
  • Batten LM; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA.
  • Jeffs LK; 14 The Institute of Cancer Research, London, United Kingdom.
  • Dodson A; 14 The Institute of Cancer Research, London, United Kingdom.
  • Martins V; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.
  • Modi A; 14 The Institute of Cancer Research, London, United Kingdom.
  • Osborne CK; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.
  • Pogue-Geile KL; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.
  • Cheang MCU; 8 Baylor College of Medicine, Houston, TX.
  • Wolmark N; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA.
  • Julian TB; 14 The Institute of Cancer Research, London, United Kingdom.
  • Fisher K; 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA.
  • MacKenzie M; 16 Allegheny Health Network Cancer Institute, Pittsburgh, PA.
  • Wilcox M; 17 International Drug Development Institute, Brussels, Belgium.
  • Huang Bartlett C; 18 Independent Cancer Patients Voice, London, United Kingdom.
  • Koehler M; 18 Independent Cancer Patients Voice, London, United Kingdom.
  • Dowsett M; 19 Pfizer, New York, NY.
  • Bliss JM; 20 Bicycle Therapeutics, Boston, MA.
  • Jacobs SA; 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom.
J Clin Oncol ; 37(3): 178-189, 2019 01 20.
Article en En | MEDLINE | ID: mdl-30523750
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Letrozol Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Letrozol Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos